Menopausal status in breast cancer patients with past chemotherapy determines long-term hypoactive sexual desire disorder

Journal of Sexual Medicine

Volumn 8, Issue 5, 2011, Pages 1486-1494

  Ochsenkühn, Robert ^a   Hermelink, Kerstin ^a   Clayton, Anita H ^b   von Schönfeldt, Viktoria ^a   Gallwas, Julia ^a   Ditsch, Nina ^a   Rogenhofer, Nina ^a   Kahlert, Steffen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Breast Cancer; Chemotherapy Associated Ovarian Failure and Sexual Dysfunction; Endocrine Treatment; Hypoactive Sexual Desire Disorder; Menopause; SIDI F

Indexed keywords

GONADORELIN;

ADULT; AMENORRHEA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HORMONAL THERAPY; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; MENOPAUSE; OVARY INSUFFICIENCY; PRIORITY JOURNAL;

EID: 79955126815     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02220.x     Document Type: Article

References (34)

1. Emilee G, Ussher JM, Perz J. Sexuality after breast cancer: A review. Maturitas 2010;66:397-407.
2. Baucom DH, Porter LS, Kirby JS, Gremore TM, Keefe FJ. Psychosocial issues confronting young women with breast cancer. Breast Dis 2005;23:103-13.
3. Basson R, Rees P, Wang R, Montejo AL, Incrocci L. Sexual function in chronic illness. J Sex Med 2010;7(Pt 2):374-88.
4. Stead ML. Sexual dysfunction after treatment for gynaecologic and breast malignancies. Curr Opin Obstet Gynecol 2003;15:57-61.
5. Sadovsky R, Basson R, Krychman M, Morales AM, Schover L, Wang R, Incrocci L. Cancer and sexual problems. J Sex Med 2010;7(Pt 2):349-73.
6. Schover LR. Premature ovarian failure and its consequences: Vasomotor symptoms, sexuality, and fertility. J Clin Oncol 2008;26:753-8.
7. Berglund G, Nystedt M, Bolund C, Sjoden PO, Rutquist LE. Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: A prospective randomized study. J Clin Oncol 2001;19:2788-96.
8. Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study. J Natl Cancer Inst 2002;94:39-49.
9. Alder J, Zanetti R, Wight E, Urech C, Fink N, Bitzer J. Sexual dysfunction after premenopausal stage I and II breast cancer: Do androgens play a role? J Sex Med 2008;5:1898-906.
10. Barni S, Mondin R. Sexual dysfunction in treated breast cancer patients. Ann Oncol 1997;8:149-53.
11. Fobair P, Stewart SL, Chang S, D'Onofrio C, Banks PJ, Bloom JR. Body image and sexual problems in young women with breast cancer. Psychooncology 2006;15:579-94.
12. Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, Bower JE, Belin TR. Quality of life at the end of primary treatment of breast cancer: First results from the moving beyond cancer randomized trial. J Natl Cancer Inst 2004;96:376-87.
13. Burwell SR, Case LD, Kaelin C, Avis NE. Sexual problems in younger women after breast cancer surgery. J Clin Oncol 2006;24:2815-21.
14. Glaus A, Boehme C, Thurlimann B, Ruhstaller T, Hsu Schmitz SF, Morant R, Senn HJ, von Moos R. Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Ann Oncol 2006;17:801-6.
15. Yang EJ, Kim SW, Heo CY, Lim JY. Longitudinal changes in sexual problems related to cancer treatment in Korean breast cancer survivors: A prospective cohort study. Support Care Cancer 2010 Apr 25 [Epub ahead of print] doi: 10.1007/s00520-010-0885-y.
16. Broeckel JA, Thors CL, Jacobsen PB, Small M, Cox CE. Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat 2002;75:241-8.
17. APA. Diagnostic and statistical manual of mental disorders-DSM-IV-TR. Washington, DC: American Psychiatric Publishing, Incorporated; 2000.
18. West SL, D'Aloisio AA, Agans RP, Kalsbeek WD, Borisov NN, Thorp JM. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med 2008;168:1441-9.
19. Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006;13:46-56.
20. Clayton AH, Segraves RT, Leiblum S, Basson R, Pyke R, Cotton D, Lewis-D'Agostino D, Evans KR, Sills TL, Wunderlich GR. Reliability and validity of the Sexual Interest and Desire Inventory-Female (SIDI-F), a scale designed to measure severity of female hypoactive sexual desire disorder. J Sex Marital Ther 2006;32:115-35.
21. Sills T, Wunderlich G, Pyke R, Segraves RT, Leiblum S, Clayton A, Cotton D, Evans K. The Sexual Interest and Desire Inventory-Female (SIDI-F): Item response analyses of data from women diagnosed with hypoactive sexual desire disorder. J Sex Med 2005;2:801-18.
22. D'Agostino L. Validating the Sexual Interest and Desire Inventory in North American women. Obstet Gynecol 2007;4:23 S.
23. Abdi H. Bonferroni and Sidak corrections for multiple comparisons. In: Salkind NJ, ed. Encyclopedia of measurement and statistics. Thousand Oaks, CA: Sage; 2007:1-9.
24. Penarrubia J, Fabregues F, Manau D, Creus M, Casamitjana R, Carmona F, Vanrell JA, Balasch J. Initial analysis of variability among basal hormone biomarkers of ovarian reserve. Reprod Biomed Online 2004;8:191-5.
25. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917-31.
26. Ghizzani A, Pirtoli L, Bellezza A, Velicogna F. The evaluation of some factors influencing the sexual life of women affected by breast cancer. J Sex Marital Ther 1995;21:57-63.
27. Aslan E, Beji NK, Gungor I, Kadioglu A, Dikencik BK. Prevalence and risk factors for low sexual function in women: A study of 1, 009 women in an outpatient clinic of a university hospital in Istanbul. J Sex Med 2008;5:2044-52.
28. Malinovszky KM, Gould A, Foster E, Cameron D, Humphreys A, Crown J, Leonard RC. Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer. Br J Cancer 2006;95:1626-31.
29. Alicikus ZA, Gorken IB, Sen RC, Kentli S, Kinay M, Alanyali H, Harmancioglu O. Psychosexual and body image aspects of quality of life in Turkish breast cancer patients: A comparison of breast conserving treatment and mastectomy. Tumori 2009;95:212-8.
30. Biglia N, Moggio G, Peano E, Sgandurra P, Ponzone R, Nappi RE, Sismondi P. Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight. J Sex Med 2010;7:1891-900.
31. Morales L, Neven P, Timmerman D, Christiaens MR, Vergote I, Van Limbergen E, Carbonez A, Van Huffel S, Ameye L, Paridaens R. Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anticancer Drugs 2004;15:753-60.
32. Mok K, Juraskova I, Friedlander M. The impact of aromatase inhibitors on sexual functioning: Current knowledge and future research directions. Breast 2008;17:436-40.
33. Derzko C, Elliott S, Lam W. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol 2007;14(suppl 1):S20-40.
34. Carter J, Goldfrank D, Schover LR. Simple strategies for vaginal health promotion in cancer survivors. J Sex Med 2010;8:549-59.